Prevalence of depression in breast cancer survivors: A systematic review of observational studies

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 4, 2013, Pages 2649-2656

  Zainal, Nor Zuraida ^a   Nik Jaafar, Nik Ruzyanei ^b   Baharudin, Azlin ^b   Sabki, Zuraida Ahmad ^a   Ng, Chong Guan ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

Author keywords

Breast; Cancer; Depression; Prev; Risk factors; Survivors

Indexed keywords

EID: 84880296553     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.4.2649     Document Type: Article

References (53)

1. Alcalar N, Ozkan S, Kucucuk S, et al (2012). Association of coping style, cognitive errors and cancer-related variables with depression in women treated for breast cancer. Jpn J Clin Oncol, 42, 940-7.
2. Alexander S, Palmer C, Stone PC (2010). Evaluation of screening instruments for depression and anxiety in breast cancer survivors. Breast Cancer Res Treat, 122, 573-8.
3. Allen JD, Savadatti S, Levy AG (2009). The transition from breast cancer 'patient' to 'survivor'. Psychooncology, 18, 71-8.
4. Azim HA Jr, de Azambuja E, Colozza M, et al (2011). Long-term toxic effects of adjuvant chemotherapy in breast cancer. Ann Oncol, 22, 1939-47.
5. Begovic-Juhant A, Chmielewski A, Iwuagwu S, et al (2012). Impact of body image on depression and quality of life among women with breast cancer. J Psychosoc Oncol, 30, 446-60.
6. Bower JE, Ganz PA, Desmond KA, et al (2000). Fatigue in breast cancer survivors: occurrence, correlates, and impact wer JE, Ganz PA, Irwin MR, et al (2011). Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol, 29, 3517-22.
7. Broeckel JA, Jacobsen PB, Balducci L, et al (2000). Quality of life after adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat, 62, 141-50.
8. Carpenter JS, Elam JL, Ridner SH, et al (2004). Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncol Nurs Forum, 31, 5591-8.
9. Chen X, Zheng Y, Zheng W, et al (2009). Prevalence of depression and its related factors among Chinese women with breast cancer. Acta Oncol, 48, 1128-36.
10. Coleman MP, Forman D, Bryant H, et al (2011). Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet, 377, 127-38
11. Den Oudsten BL, Van Heck GL, Van der Steeg AF, et al (2009). Predictors of depressive symptoms 12 months after surgical treatment of early-stage breast cancer. Psychooncology, 18, 1230-7.
12. Deshields T, Tibbs T, Fan MY, Taylor M (2006). Differences in patterns of depression after treatment for breast cancer. Psychooncology, 15, 398-406.
13. Eversley R, Estrin D, Dibble S, et al (2005). Post-treatment symptoms among ethnic minority breast cancer survivors. Oncol Nurs Forum, 32, 250-6.
14. Fann JR, Thomas-Rich AM, Katon WJ, et al (2008). Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry, 30, 112-26.
15. Green BL, Rowland JH, Krupnick JL, et al (1998). Prevalence of posttraumatic stress disorder in women with breast cancer. Psychosomatics, 39, 102-11.
16. Hann D, Winter K, Jacobsen P (1999). Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res, 46, 437-43.
17. Hill J, Holcombe C, Clark L, et al (2011). Predictors of onset of depression and anxiety in the year after diagnosis of breast cancer. Psychol Med, 41, 1429-36.
18. Hopwood P, Sumo G, Mills J, et al (2010). The course of anxiety and depression over 5 years of follow-up and risk factors in women with early breast cancer: results from the UK Standardisation of Radiotherapy Trials (START). Breast, 19, 84-91.
19. Howard-Anderson J, Ganz PA, Bower JE, Stanton AL (2012). Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst, 104, 386-405.
20. Hsiao FH, Chang KJ, Kuo WH, et al (2013). A longitudinal study of cortisol responses, sleep problems, and psychological wellbeing as the predictors of changes in depressive symptoms among breast cancer survivors. Psychoneuroendocrinology, 38, 356-66.
21. Inagaki M, Matsuoka Y, Sugahara Y, et al (2004). Hippocampal volume and first major depressive episode after cancer diagnosis in breast cancer survivors. Am J Psychiatry, 161, 2263-70.
22. Jang JE, Kim SW, Kim SY, et al (2012). Religiosity, depression, and quality of life in Korean patients with breast cancer: a 1-year prospective longitudinal study. Psychooncology, 22, 922-9.
23. Johnson JL, Minarik PA, Nystrom KV, et al (2006). Poststroke depression incidence and risk factors: an integrative literature review. J Neurosci Nurs, 38, 316-27.
24. Karakoyun-Celik O, Gorken I, Sahin S, et al (2010). Depression and anxiety levels in woman under follow-up for breast cancer: relationship to coping with cancer and quality of life. Med Oncol, 27, 108-13.
25. Khan F, Amatya B, Pallant JF, Rajapaksa I (2012). Factors associated with long-term functional outcomes and psychological sequelae in women after breast cancer. Breast, 21, 314-20.
26. Lorizio W, Wu AH, Beattie MS, et al (2012). Clinical and biomarker predictors of side effects from tamoxifen. Breast Cancer Res Treat, 132, 1107-18
27. Makambi KH, Williams CD, Taylor TR, et al (2009). An assessment of the CES-D scale factor structure in black women: The Black Women's Health Study. Psychiatry Res, 168, 163-70.
28. Mehnert A, Koch U (2008). Psychological comorbidity and health-related quality of life and its association with awareness, utilization, and need for psychosocial support in a cancer register-based sample of long-term breast cancer survivors. J Psychosom Res, 64, 383-91.
29. Mitchell AJ, Lord K, Symonds P (2012). Which symptoms are indicative of DSMIV depression in cancer settings? An analysis of the diagnostic significance of somatic and nonsomatic symptoms. J Affect Disord, 138, 137-48.
30. Mitchell AJ, Meader N, Symonds P (2010). Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: a meta-analysis. J Affect Disord, 126, 335-48.
31. Moher D, Liberati A, Tetzlaff J, Altman DG (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ, 339, 2535.
32. Morrill EF, Brewer NT, O'Neill SC, et al (2008). The interaction of post-traumatic growth and post-traumatic stress symptoms in predicting depressive symptoms and quality of life. Psychooncology, 17, 948-53.
33. Ng CG, Boks MP, Zainal NZ, de Wit NJ (2011). The prevalence and pharmacotherapy of depression in cancer patients. J Affect Disord, 131, 1-7.
34. Odle TG (2011). Breast cancer survivorship and surveillance. Radiol Technol, 83, 63-87.
35. Park BW, Hwang SY (2012). Unmet needs of breast cancer patients relative to survival duration. Yonsei Med J, 53, 118-25.
36. Pan L, Han Y, Sun X, et al (2010). FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: a meta-analysis. J Cancer Res Clin Oncol, 136, 1007-22.
37. Phillips KA, Osborne RH, Giles GG, et al (2008). Psychosocial factors and survival of young women with breast cancer: a population-based prospective cohort study. J Clin Oncol, 26, 4666-71.
38. Popoola AO, Adewuya AO (2012). Prevalence and correlates of depressive disorders in outpatients with breast cancer in Lagos, Nigeria. Psychooncology, 21, 675-9.
39. Pumo V, Milone G, Iacono M, et al (2012). Psychological and sexual disorders in long-term breast cancer survivors. Cancer Manag Res, 4, 61-5.
40. Qiu J, Yang M, Chen W et al (2012). Prevalence and correlates of major depressive disorder in breast cancer survivors in Shanghai, China. Psychooncology, 21, 1331-7.
41. Rabin EG, Heldt E, Hirakata VN, et al (2009). Depression and perceptions of quality of life of breast cancer survivors and their male partners. Oncol Nurs Forum, 36, 153-8.
42. Schou I, Ekeberg O, Ruland CM, et al (2004). Pessimism as a predictor of emotional morbidity one year following breast cancer surgery. Psychooncology, 13, 309-20.
43. Schreiber JA (2011). Image of God: effect on coping and psychospiritual outcomes in early breast cancer survivors. Oncol Nurs Forum, 38, 293-301.
44. Speer JJ, Hillenberg B, Sugrue DP, et al (2005). Study of sexual functioning determinants in breast cancer survivors. Breast J, 11, 440-7.
45. Tangney CC, Young JA, Murtaugh MA, et al (2002). Selfreported dietary habits, overall dietary quality and symptomatology of breast cancer survivors: a cross-sectional examination. Breast Cancer Res Treat, 71, 113-23.
46. Ullrich PM, Rothrock NE, Lutgendorf SK, et al J (2008). Adjustment and discussion of cancer: A comparison of breast and prostate cancer survivors. Psychol Health, 23, 391-406.
47. Vahdaninia M, Omidvari S, Montazeri A (2010). What do predict anxiety and depression in breast cancer patients? A followup study. Soc Psychiatry Psychiatr Epidemiol, 45, 355-61.
48. Van Wilgen CP, Dijkstra PU, Stewart RE, et al (2006). Measuring somatic symptoms with the CES-D to assess depression in cancer patients after treatment: comparison among patients with oral/oropharyngeal, gynecological, colorectal, and breast cancer. Psychosomatics, 47, 465-70.
49. Wang GL, Hsu SH, Feng AC, et al (2011). The HADS and the DT for screening psychosocial distress of cancer patients in Taiwan. Psychooncology, 20, 639-46.
50. Warmenhove F, Van Rijswijk E, Engels Y, et al (2012). The Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in Dutch advanced cancer patients. Support Care Cancer, 20, 319-24.
51. Watson M, Haviland JS, Greer S, et al (1999). Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet, 354, 1331-6.
52. Weinberger T, Forrester A, Markov D, et al (2010). Women at a dangerous intersection: diagnosis and treatment of depression and related disorders in patients with breast cancer. Psychiatr Clin North America, 33, 409-22.
53. Zainal NZ, Booth S, Huppert FA (2012). The efficacy of mindfulness-based stress reduction on mental health of breast cancer patients: a meta-analysis. Psychooncology, [Epub ahead of print].